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Marie-Paule Vasson1,2,3*, Marie-Chantal Farges1,2, Nicolas Goncalves-Mendes1,2, Jérémie Talvas1,2, Josep Ribalta4,
Brigitte Winklhofer-Roob5, Edmond Rock1,2 and Adrien Rossary1,2Abstract
Background: As the European population is getting older, there is growing need in scientific data on how to
achieve healthy and successful aging. A decline in immune function with age is unanimously supported by many
epidemiological and clinical observations, with a decrease in T-cell mediated function encompassing a large part of
this alteration. In the EU-funded VITAGE project, the effects of aging on biomarkers of immune status are being
studied in three European countries. According to strict inclusion/exclusion criteria, a cohort of 300 healthy male
non-smoking 20–75 years old volunteers were enrolled in France (n = 99), Spain (n = 100) and Austria (n = 101).
In each country, the volunteers were classified as a function of age (one age group per decade). Biomarkers of
immune status were determined including delayed-type hypersensitivity tests, measurement of lymphocyte surface
markers, and serum determinations of interleukin-2, complement fractions and immunoglobulins.
Results: There were moderate differences in the biomarkers of immune status of the VITAGE study volunteers
among the three European centres. The percentage of Natural Killer (NK) cells was 156% and 142% higher in Spain
as compared to France and Austria, respectively (p < 0.0001), and this increase was observed at any age group
above 30 years. Comparison between age-groups showed that in Spain, but not in France or Austria, older
individuals had significantly a lower B lymphocyte distribution and conversely, a higher NK cell distribution.
Moreover, the CD4/CD8 ratio was positively correlated with age in Austrian subjects (p < 0.0001).
Conclusion: Our results provide evidence of an increased NK cell distribution in the elderly, especially in the
Spanish population. NK cell status may predict morbidity and mortality in the elderly, emphasizing the importance
of innate as well as adaptive immunity in ensuring healthy longevity and cancer resistance, possibly in link with the
Mediterranean diet.
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The mechanisms by which a successful aging occurs in
humans, i.e. aging in good psychophysical conditions
[1], are immunologically characterized by preserved
lymphoproliferative responses and Natural Killer (NK)
cell cytotoxicity as well as conserved antigen presenta-
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reproduction in any medium, provided the orevidence of a competent immune system, programmed
with increase in the number and/or the proportion
of NK cells to scan presumably for virus-infected,
stressed and malignant cells [4]. In others studies, an
increase in NK cells showing a mature phenotype was
found in healthy elderly donors who had an NK cyto-
toxic capacity of total peripheral blood lymphocytes
preserved [5,6]. Such preservation in healthy elderly
may be due to a high number of NK cells in order to
compensate low NK cell cytotoxicity and cytokine and
chemokine production [7].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Baseline immune parameters for the 3
populations
France Austria Spain Total
(n = 99) (n = 101) (n = 100) (n = 300)
IgG (g/l) 11.1 ± 0.2 11.0 ± 0.2 11.1 ± 0.3 11.1 ± 0.1
IgA (g/l) 2.60 ± 0.10 2.20 ± 0.10 2.72 ± 0.12 2.50 ± 0.06
IgM (g/l) 1.20 ± 0.06 1.00 ± 0.04 1.18 ± 0.07 1.10 ± 0.03
C3 (g/l) 1.00 ± 0.02 1.00 ± 0.01 1.09 ± 0.02 1.00 ± 0.01
C4 (g/l) 0.20 ± 0.01 0.20 ± 0.01 0.25 ± 0.01 0.20 ± 0.00
sIL2-R (pmol/l) 38.3 ± 1.7 36.0 ± 2.1 39.3 ± 2.0 38.8 ± 1.4
Means ± SEM.
Two-way ANOVA was performed to discriminate among the two factors age-
group, country and their interactions. No interaction was obtained between
the two factors and no effect was observed whatever the factor.
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mously recognized and supported by epidemiologic and
clinical studies [8]. We have reported that several meta-
bolic and nutritional factors, including insulin, retinoic
acid or carotenoids affect the immune response in func-
tion of age in healthy volunteers [9-13]. However, the
development of age-related changes in health status in
elderly men have led to conflicting results and these dis-
crepancies may be partially ascribed to the population
tested, i.e. presence of concomitant pathologic disorders
or nutritional deficiencies that may affect the immune
status (reviewed in [14-17]). To overcome this problem,
volunteers in the present study were recruited according
to the SENIEUR protocol, which used strict clinical
and biological inclusion criteria (i.e. good nutritional
status, absence of disease, no sign of inflammation or
infection, no drug delivery) as well as rigorous exclu-
sion criteria with detailed measurement of the immune
markers [18].
In Europe, the prevalence and the geographical
variation of symptoms associated with a putative “aging
syndrome” have never been documented. A recent
multi-centre study was designed from male volunteers
to specify age-related changes in hormone levels, socio-
economic and lifestyle factors that exist across Europe
[19]. However, the effects of aging on biomarkers of im-
mune status, measured at baseline in healthy individuals
from different European countries, have never been
reported. The geographical comparisons are of particular
interest, since in addition to the immunological status,
various potential predisposing risk factors such as the
dietary, lifestyle habits, genetic and socioeconomic fac-
tors are different from a country to another [20,21].
The aim of the present work was to provide descrip-
tive information on the biomarkers of immune status in
300 healthy volunteers aged between 20–75 years
recruited in Austria, Spain and France and having parti-
cipated in our previous EU-funded studies [22-25]. The
number of about 100 subjects in each country has been
chosen on the basis of the results of power calculations for
those biomarkers with known distribution in humans, and
assuming to detect biologically significant differences in
each case. The decision to limit this project only to male
subjects has been based on the observation that changes in
hormonal status that occur in women, both within and
between subjects of this wide age range, may affect the
immune status [26].
Our preliminary and primarily descriptive analyses
showed that there are moderate differences in the im-
mune status of middle-aged to older inhabitants of the
three European centres. Moreover, blood leukocyte
phenotypes, especially NK and CD8 cell distribution,
were markedly increased in elderly volunteers from the
Spanish centre, thus suggesting a specific immunepattern possibly in link with environmental factors
such as the Mediterranean diet and the lifestyle.
Results
Determination of systemic biomarkers of immune status
The measurements of all immune biomarkers tested
(IgG, IgA, IgM, C3, C4, sIL-2R) were in the usual
physiological range observed in others European coun-
tries [27,28] and there was no biological difference from
a country to another (Table 1). In France, Spain and
Austria, individuals had IgA levels positively correlated
with age (r2 = +0.2, p = 0.04). Accordingly, an age effect
was found for IgA serum levels which were significantly
higher in subjects aged 40 years old or more compared
to younger individuals (Figure 1). Comparison between
age groups showed no difference among the others
serum immune biomarkers tested (IgG, IgM, C3, C4,
sIL-2R, data not shown).
Determination of delayed-type hypersensitivity
Considering the delayed-type hypersensitivity (DTH)
responses, the cumulative score and the number of posi-
tive reactions were higher in Austria (22.7 ± 1.2 and
6.9 ± 0.1, respectively) than in France (17.7 ± 0.9 and 3.4
± 0.2, respectively) and in Spain (7.1 ± 0.8 and 1.1 ± 0.1,
respectively) (Table 2). For both Austria and France, the
cumulative score was in the normal range while it was
slightly hypoergic in Spain as defined by Knicker et al.
[29]. In each of the three countries, the number of posi-
tive responses was more frequent for tetanus and tuber-
culin. In Spanish volunteers, a positive correlation was
found between age and the cumulative score (p = 0.04).
Accordingly, the cumulative score was significantly
lower in the age group 20–29 y (2.6 ± 0.9) compared to
the oldest age groups 40–49 y (8.7 ± 1.7), 50–59 y (8.3 ±
2.2) and 60–69 y (9.4 ± 2.3). In French and Austrian
volunteers, no correlation was found between age and
either the number of positive reactions or the cumula-
tive score (data not shown).
Figure 1 IgA serum levels in function of age of the volunteers
from the 3 countries. Results are presented as means ± SEM.
Two-way ANOVA was performed to discriminate among the
two factors age-group, country and their interaction followed
by a post-hoc Newman-Keuls test. A significant age group-related
effect was observed independently of the country-related factor. Means
sharing different superscript letters are significantly different: a≠b≠c,
p < 0.05.
Table 3 Lymphocyte phenotype distribution (%) for the 3
populations
France Austria Spain ANOVA
(n = 99) (n = 101) (n = 100)
T Lymphocytes
Total 70.2 ± 0.6 70.5 ± 1.1 67.2 ± 1.1 NS
CD4 41.1 ± 0.7a 44.4 ± 1.1b 36.7 ± 0.9c <0.0001
CD8 29.7 ± 0.8a 27.7 ± 0.7a 34.8 ± 1.1b <0.0001
CD4/CD8 1.5 ± 0.1a 1.8 ± 0.1b 1.2 ± 0.1c <0.0001
B Lymphocytes 13.7 ± 0.4a 16.0 ± 0.7b 13.3 ± 0.8a 0.01
NK cells 14.8 ± 0.7a 16.2 ± 0.7a 23.1 ± 1.0b <0.0001
Means ± SEM.
Two-way ANOVA was performed to discriminate among the two factors age-
group, country and their interaction followed by a post-hoc Newman-Keuls
test. A significant country-related effect was observed independently of the
age-group: a≠b≠c, p < 0.01, NS: not significant.
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CD4 and CD8 T cell distribution
The proportion (in %) of total lymphocytes was not differ-
ent either between the three countries (Table 3) or between
the age groups for each country (data not shown). However,
the distribution of CD4 lymphocytes was significantly
higher in Austria (44.0 ± 1.1) than in France (41.1 ± 0.7) or
in Spain (36.7 ± 0.9) while the opposite was observed for
CD8 lymphocytes whose percentage was higher in Spain
(34.8 ± 1.1) than in France (29.7 ± 0.8) or in Austria (27.7 ±
0.7) (Table 3). These findings were markedly observed in
volunteers aged 40 years old or more (Figure 2). The CD4/
CD8 ratio was significantly different in Austria (1.8 ± 0.1),
in France (1.5 ± 0.1) and in Spain (1.2 ± 0.1). In Austrian
volunteers, age was positively correlated with CD4 cells dis-
tribution (r2 = +0.356, p = 0.0002), with the CD4/CD8 ratioTable 2 Delayed-type hypersensitivity in the 3 populations
France
(n = 99)
Number of positive reactions 3.4 ± 0.2a
Cumulative score (mm) 17.7 ± 0.9a
Proteus mirabilis 2.4 ± 0.2a
Trichophyton 0.9 ± 0.1a
Candida albicans 2.3 ± 0.2a
Tetanus 4.2 ± 0.3a
Diphteria 1.5 ± 0.2a
Streptococcus 0.9 ± 0.2a
Tuberculin 5.4 ± 0.3a
Mean ± SEM.
Two-way ANOVA was performed to discriminate among the two factors age-group,
significant country-related effect was observed independently of the age-group: a≠(r2 = +0.452, p < 0.0001) and was negatively correlated with
CD8 cell distribution (r2 =−0.449, p < 0.0001). Moreover,
age was positively correlated with CD8 cell distribution in
Spanish subjects (r2 = +0.338, p = 0.0005).B and NK cell distribution
The lowest percentage of B lymphocytes was observed
in the Spanish individuals (Table 3), especially in those
above 50 years old (Figure 3a). Conversely, the percent-
age of NK cells was significantly higher in Spain (23.1 ±
1.0) than in France (14.8 ± 0.7) or Austria (16.2 ± 0.7)
(Table 3). This increase was observed in the Spanish
population at any age group over 30 y (Figure 3b). Age
was negatively correlated with B cell distribution in
Spanish volunteers (r2 = −0.436, p < 0.0001). In contrast,
age was positively correlated with NK cell distribution in
Spanish (r2 = +0.345, p = 0.0004) and French (r2 = +0.349,
p = 0.0004), but not in Austrian subjects.Austria Spain ANOVA
(n = 101) (n = 100)
6.9 ± 0.1b 1.1 ± 0.1c <0.0001
22.7 ± 1.2b 7.1 ± 0.8c <0.0001
3.2 ± 0.2b 0.6 ± 0.2c <0.0001
1.4 ± 0.2b 0.2 ± 0.1c <0.0001
2.7 ± 0.3a 0.4 ± 0.1b <0.0001
6.4 ± 0.4b 2.5 ± 0.3c <0.0001
2.8 ± 0.4b 0.6 ± 0.2c <0.0001
1.3 ± 0.2b 0.2 ± 0.1c <0.0001
4.5 ± 0.5b 2.7 ± 0.4c <0.0001
country and their interactions followed by a post-hoc Newman-Keuls test. A
b≠c, p < 0.0001.
ac
b
Figure 2 T lymphocyte distributions and ratio. CD4 (a) and CD8 (b) lymphocyte distributions and CD4/CD8 ratio (c). T lymphocyte distribution
and CD4/CD8 ratio were compared for each age group between the three countries (A = Austria; F = France; S = Spain). Data are reported as means ±
SEM, one way ANOVA followed by a Newman-Keuls test, different superscript letters indicate a statistical difference between country (a≠b≠c, p < 0.05).
a b
Figure 3 B and NK lymphocyte distribution. B (a) and NK (b) cell distribution were compared for each age group between the three countries
(A = Austria; F = France; S = Spain). Data are reported as means ± SEM, one way ANOVA followed by a Newman-Keuls test, data that share different
superscript letters indicate a statistical difference between country (a≠b≠c, p < 0.05).
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distribution was significantly impaired in elderly Spanish
subjects over 60 years old (Figure 4c). The same age cut-
off (60 y) was observed for NK cell increase in Spanish
and French (Figure 4c and a) but not in Austrian subjects
(Figure 4b).
CD45RA and CD45RO CD4 lymphocyte distribution
CD45RA and CD45RO CD4 cell distributions (in %)
were markedly higher in Austria (74.9 ± 1.1 and
68.8 ± 1.0, respectively) than in France (70.1 ± 0.8 and
60.8 ± 0.1, respectively) or Spain (70.3 ± 1.1 and 55.4 ±
1.9, respectively). Distribution between naïve (CD45RA)
and memory (CD45RO) CD4 cells was modified by
aging (Figure 5). As expected, percentages of CD45RA
CD4 were higher in young adults than in elderly subjects,
and conversely, percentages of CD45RO CD4 cells were
lower in young adults than in older subjects. Age was nega-
tively correlated with CD45RA CD4 cell distribution in
Austria (r2 = −0.376, p = 0.0001) and Spain (r2 = −0.430,
p < 0.0001) but not in France. On the other hand, age was
positively correlated with CD45RO CD4 cell distribution
only in France (r2 = +0.289, p = 0.0036).a
c
Figure 4 B lymphocyte and NK cell distribution. The B and NK cell distr
analysis was done by one way ANOVA followed by a Newman-Keuls test; p
letters are significantly different (a≠b≠c≠d).CD11b and CD18 PMN distribution
Adhesion antigens (CD11b, CD18) expression (in %) of
polymorphonuclear neutrophils (PMNs) was not af-
fected, neither by the geographical location (France:
99.5 ± 0.1; Austria: 99.9 ± 0.02; Spain: 99.9 ± 0.01 for
CD11b and France: 99.8 ± 0.1; Austria: 99.9 ± 0.02; Spain:
99.9 ± 0.01 for CD18), nor by the age of the volunteers
(data not shown).
Discussion
The purpose of this work was to determine the bio-
markers of immune status in healthy volunteers and to
provide a geographical comparison of these biomarkers
between three European countries. Despite different
dietary habits, lifestyle, genetic and socio economic
factors, we found only moderate variations in the bio-
markers, the most striking being an increased distribu-
tion of NK cells in Spain, compared to France and
Austria, while a higher DTH response and an enhanced
CD4/CD8 ratio were found in Austria. Interestingly, the
immune parameters in our French volunteers had
constantly intermediate values between those measured
in Austrian and Spanish individuals, thus reflecting theb
ibution was compared for each age group in each country. Statistical
< 0.05 was considered significant and data with different superscript
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Figure 5 CD45 lymphocyte distribution. Naïve (CD45RA+) and memory (CD45RO+) CD4+ lymphocyte distribution was compared for each age
group in each country. Values are means ± SEM. Statistical analysis was done by one way ANOVA followed by a Newman-Keuls test, p < 0.05 was
considered significant. Values with different superscript letters are significantly different (a≠b≠c≠d≠e; a'#b'#c').
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status and possible gradual differences in the dietary,
lifestyle habits, environmental, genetic and socio-
economic factors between Southern and Northern
Europe. Immunosenescence affects all compartments
of the immune system. Age changes were demon-
strated in T lymphocytes and in innate immunity,
including NK cells. A decline in CD4 count, a rise in
CD8 compartment and an increase in the NK cell
numbers with well-preserved [30] or reduced cytotoxic
function [31,32] has been considered as a “remodel-
ling” of the immune compartment with aging [30].
NK cell status and longevity
In our Spanish population (mean age 46.3 y), we ob-
served an increase in the percentage of NK cells in eld-
erly people when compared to young controls (32.3 ± 3.4
in elderly over 70 y vs 19.1 ± 2 in young aged 20 to
29 y). This is consistent with the findings of Borrego
et al. who also observed a significant increase in the per-
centage of CD56+ cells in aged Spanish donors when
compared to the young controls (29.1 ± 10.1 in elderly
over 81 y vs 14.8 ± 5.3 in young aged 32 y) [33].Moreover, we found that the percentage of NK cells was
significantly higher in Spanish than in French or Aus-
trian subjects, and this was observed at any age group
above 30 years. The NK cell status is thought to be an
important component of the aging immune system [5,7]
and can predict morbidity and mortality in the elderly.
Low NK cell number and function are associated with
increased mortality and greater risk of severe infections
in elderly subjects [34,35]. Conversely, a well preserved
functional status of NK cells until very advanced age is
linked to healthy ageing and longevity [5], emphasizing
the importance of innate as well as adaptive immunity
in ensuring healthy longevity [30] and possibly cancer
resistance [36,37]. Thus, our results may be related to
the fact that life expectancy at birth is greater in Spain
(over 80 y) as compared to France or Austria (below
80 y) [38].
Environmental factors and immune biomarkers
An aging-related deficiency in the immunosurveillance
system (especially NK cells) may play a role in patho-
genesis and in particular, in cancer. Since many environ-
mental factors are mutagenic and promote cancer, we
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of exposure to these factors and their effects on immune
system. For example, pollution affects the number of NK
cells but also of CD4+, CD8+ and B lymphocytes [39]. As
such, we cannot rule out that the differences in lympho-
cyte distribution observed between the three countries
may be explained by differential environmental factors
such as pollution or others.
Impact of diet on immune aging
As the consumption of fruits and vegetables is higher in
Spain than in the other European countries [40,41], an
important role for the dietary patterns in the healthy
aging of the elderly has been suggested [42,43]. In
Europe, prospective studies have shown that adherence
to a typical Mediterranean diet is associated with lower
mortality and increased longevity [41,44-46]. The effects
of such a diet on immune status have not been reported.
In one recent study conducted in patients with high risk
of cardiovascular diseases, the Mediterranean diet, com-
pared to a control low-fat diet, seems to down-regulate
immune cell activation but not T lymphocyte percent
change [47]. In the meta-analysis of 12 prospective stud-
ies [48], a two-point increase in a score of Mediterra-
nean diet adherence was associated with improved
health status, as shown by a significant reduction in
mortality (9%), cardiovascular diseases (9%), cancer (6%),
and the incidence of Parkinson’s and Alzheimer’s disease
(13%). However, as this benefit was also apparent in
non-Mediterranean populations [47,48], a direct role of
diet on aging remains unclear and cannot fully explain
our results. NK cells and their cytolytic activity have also
been related to nutrition including vitamin D and an-
thropometric markers [49]. Preliminary results from an
Irish study indicate a small negative relationship be-
tween NK cell number and body mass index [4].
Age effect on immune status
In our well-defined healthy population, we found serum
IgA levels were correlated with age, which is in agree-
ment with other studies [27] and suggests either a com-
plex derangement of B cell function with age [50] or a
remodelling of the immune system rather than a deteri-
oration [51]. Comparison between age groups showed
that IgA levels were higher in subjects above 40 y. It is
noteworthy that the same cut-off was observed for other
immune biomarkers (B, CD4 and CD8 cell distribution,
CD4/CD8 ratio), suggesting that a decline in immune
function leading to the healthy aging process may start
in the early age. By recruiting only male volunteers in
our study, we have excluded any possible influence of
immune status by hormonal changes that occur with
age in women. We also found alterations in the immune
capacity reflected by a greater proportion of NK cells, adecrease in B lymphocytes but a stable number of T
cells. When all European volunteers were classified as a
function of age, NK distribution was significantly in-
creased with age (17% in 20–29 y vs 24% in 70 y), in
agreement with previous findings ([52]: 18% in 29 y vs
30% in 86 y; [53]: 14% in 20–29 y vs 20% in 70–75 y).
Although the alterations of NK cells and other innate
immune cells with aging are generally less marked than
those seen with T cells [16,54], we observed that in our
subjects, a greater correlation with age was found for
NK cells (r2 = +0.21, p = 0.0002) than for CD4/CD8 ratio
(r2 = +0.14, p = 0.01). A similar positive correlation bet-
ween age and CD4/CD8 ratio in Irish individuals was
reported by Rea et al. [4]. Moreover, we observed a shift
from a predominance of naïve T cells towards T cells ex-
pressing memory phenotypes from the youngest to the
oldest age groups, as previously reported [12,55]. This
shift may result from the age-related repetition of anti-
genic challenges.
Vaccination and immune response
The mechanisms of vaccination are complex and may
differ depending on the allergen and the route of
immunization. We observed that the most frequent
DTH responses were observed for tetanus and tubercu-
lin which represent two common antigens. As the vac-
cination coverage against the different antigens used in
our study has not been reported in Europe, it is unclear
why we observed enhanced DTH responses in our Aus-
trian volunteers, as compared to the subjects from the
other two European centres. Whether this finding could
be explained by a better vaccination status or linked to
booster doses in elderly people in Austria is unlikely.
Based on the influenza vaccination coverage rate in the
general population (aged 14 to 75 years), it was of 26.4%
in France and 23.7% in Spain, during the period 2007-
2008 [56]. By comparison, the vaccination coverage rate
during the same period was significantly lower in Austria
(16.0%), where vaccination is costly and results in socio-
economic inequalities regarding immunization in the
general population [57]. In addition, adherence to vac-
cination programs may differ between European coun-
tries. For example, tuberculin skin testing to make
decision about BCG revaccination was described to be
routinely performed in France but not in Austria [58].
Moreover, independently of the vaccination policy, the
low cutaneous reactivity in Spain might be in part linked
to dietary habits particularly fruits and vegetables con-
sumption as previously published [59].
Conclusion
This study compares for the first time the immune
status in three European countries and describes
the effects of aging on immune cell distribution. The
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explained by genetic, environmental, dietary and socio-
economic variations. This variability should be taken
into account when estimating, in future nutrition re-
search studies, the actual immune status of healthy
individuals with different geographical origins.
Methods
Subjects and experimental procedure
Three-hundred healthy male non-smoking subjects,
aged 20–75 years (stratified by age), were recruited in
Clermont-Ferrand, France (n = 99), Graz, Austria
(n = 101), and Reus, Spain (n = 100), as part of the
European Commission-funded Research and Techno-
logy Development (RTD) project of the 5th Framework
Program, specific RTD Program “Quality of Life and
Management of Living Resources”, Key Action#1, “Food,
Nutrition, and Health”, entitled “Vitamin A, Vitamin E, and
Carotenoid Status and Metabolism during Ageing: Func-
tional and Nutritional Consequences”, acronym VITAGE
(Contract QLK1-CT-1999-00830) [22,23]. The study proto-
col was approved by the local Ethics Committee of the
three recruiting centres and was performed in accordance
with the ethical standards of the Declaration of Helsinki. A
written informed consent was obtained from all partici-
pants prior to their inclusion in the study. After informative
sessions, a trained medical doctor conducted a personal
interview to obtain information on anthropometric mea-
surements, personal history, lifestyle, use of medications,
physical activity, smoking habits, and use of dietary supple-
ments containing vitamins or trace elements. Exclusion cri-
teria were familial hypercholesterolemia, chronic diseases
(including diabetes, cancer, cardiac insufficiency, neuro-
logical diseases, inflammatory diseases and chronic diseases
of the liver, lung, or thyroid, non stable hypertension, de-
mentia, and infectious diseases known to affect the immune
system, such as human immunodeficiency virus and hepa-
titis C), vaccination during the past 2 months, alcoholism
or drug addiction, competitive sport activities, and the con-
sumption of special diets or dietary supplements in the past
3 months. All volunteers from a given centre had the usual
diet of their respective country, which is the diet of the
general population. Venous blood samples were collected
from subjects in the fasting state for serum and leukocyte
isolation and storage until analysis. The SENIEUR protocol
standardized the selection of the volunteers for immuno-
logical studies [18].
The mean age ± SEM of the volunteers from France,
Austria and Spain was 46.8 ± 1.5 y, 45.6 ± 1.5 y and
46.3 ± 1.6 y, respectively (no significant difference). In
each country, the volunteers were classified in six
different age groups: 20–29 y (n = 59), 30–39 y (n = 55),
40–49 y (n = 59), 50–59 y (n = 51), 60–69 y (n = 56) and
70–75 y (n = 20). This approach allowed us either todirectly compare two age groups or to describe the
evolution of the study variables as a function of age.
Determination of systemic biomarkers of immune status
Serum immunoglobulin (IgG, IgA, IgM) and comple-
ment fraction (C3, C4) concentrations were quantified by
immunonephelemetry (Array protein system, Beckman-
Coulter, Villepinte, France), using human antibodies
(Beckman-Coulter). Values are expressed in g/l.
Serum soluble interleukin 2 receptor (sIL-2R) concen-
tration (pmole/l) was assayed by ELISA (Immunotech
kit, Beckman-Coulter).
Determination of delayed-type hypersensitivity skin test
response
To determine DTH skin response, we used the Multitest
CMI® skin applicator (Pasteur-BioMérieux, Lyon, France)
against seven antigens (Tetanus, Diphteria, Streptococcus
(C group), Tuberculin, Candida Albicans, Trichophyton,
Proteus Mirabilis) and a glycerin negative control.
Multitest® was applied on healthy arm skin for at least 5 se-
conds. The skin tests were read at 48 h after application by
measuring for each antigen the induration response (mean
of two perpendicular diameters) using a gradual scale. In-
duration ≥2 mm was recorded as positive response and
corrected by substracting the negative control, if any [60].
The cumulative score was calculated as the sum of all anti-
gen indurations. This score was considered as “hypoergic”
(<10 mm with at least one positive response ≥2 mm) or
“anergic” (no response greater than 2 mm) or “normal”
(≥10 mm with at least one positive response ≥2mm)
according to Kniker et al. [29].
Determination of blood leukocyte phenotype
In each recruitment centre, blood leukocytes were isolated
using Ficoll density gradient (Histopaque®1077 and 1119,
Sigma-Aldrich) and then cryopreserved [61]. Briefly, cells
were progressively frozen in a Cryo-Med liquid nitrogen
freezer and conserved at −196°C during at most 6 months.
Such cryopreservation did not affect the cell surface
markers [62]. All analyses were done in the same labora-
tory: lymphocyte subpopulations were measured, as pre-
viously described [13], using flow cytometry with an Epics
XL (Beckman-Coulter) after labelling with fluorochrome-
conjugated monoclonal antibodies (Beckman-Coulter) :
CD3-PC5, CD4-RD1, CD8-ECD, CD45RA-FITC, CD45RO-
FITC, CD19-ECD, CD56-PE (Beckman-Coulter) corres-
ponding to total T cells (CD3+), T helper/inducer (CD4+), T
suppressor/cytotoxic (CD8+), B lymphocytes (CD19+) and
NK cells (CD56+), respectively. Results were expressed in
percentages of total leukocyte populations. PMN CD ex-
pression was determined by flow cytometry using anti-
CD11b-FITC and anti-CD18-FITC (Beckman-Coulter) and
reported in percentage of total PMN population.
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pensation settings in case of multiple labellings were
done and intra- and inter-assays were recorded as pre-
viously reported [13].Statistics
All statistical analyses were run on Statview SAS, version
5. The experimental design comprised two cross-fixed
factors with the factor “aging” as six groups and the fac-
tor “country” as three groups. This design allowed statis-
tical analysis by two-way measures analysis of variance
(ANOVA) in order to discriminate between the age ef-
fects and the country-related effects. The level of signifi-
cance was set at p ≤ 0.05 for this test. When the
ANOVA indicated significant interactions, the Newman-
Keüls post-hoc test was used to identify differences
between individual means. When no significant inter-
action was found, the marginal means were calculated
and compared with a one way ANOVA followed by a
Newman-Keüls test. Results are expressed as means ±
SEM and various superscript letters (a, b, c, d, e) are
significantly different (p < 0.05). To assess the correla-
tions between baseline immune parameters and age,
Spearman’s rank correlation tests was used for dependent
groups and the Kruskal–Wallis test was performed for
independent groups.
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